2026-02-26
Professional hybridoma monoclonal antibody production services including mouse immunization, cell fusion, hybridoma screening, and stable monoclonal antibody development.
2026-02-25
Advanced single B cell antibody discovery platform including antigen-specific B cell sorting, sequencing, and recombinant antibody expression for therapeutic development.
2026-02-25
Advanced phage display platform for antibody discovery and library screening. Human antibody and peptide phage display technology for high-affinity recombinant antibody development.
2026-02-25
Custom ion channel stable cell line development for functional assays and drug screening. Validated mammalian expression systems compatible with patch clamp and electrophysiology studies.
2026-02-25
Custom GPCR stable cell line development for functional assays and drug screening. Reliable mammalian GPCR expression systems with validated signaling and stable integration.
2026-02-25
Comprehensive stable cell line development services including CRISPR gene editing and mammalian cell engineering. Reliable, scalable, and GMP-compatible cell line solutions.
2026-02-25
Custom CRISPR knockout cell line development with stable genome editing. Homozygous and isogenic KO models for functional studies, disease research, and drug target validation.
2026-02-25
Custom CRISPR knock-in cell line development with stable genome integration. HDR-mediated site-specific gene insertion, endogenous tagging, and isogenic cell line engineering services.
2026-02-25
Custom stable gene knockdown cell lines using shRNA, lentiviral delivery, and CRISPRi technology. Reliable gene silencing models for functional studies and drug target validation.
2026-02-25
Custom reporter cell line development for luciferase, fluorescent, and CRISPR knock-in systems. Stable cell-based assay models for drug screening and pathway analysis.
